We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+15.41%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$6.93B
AUM Growth
+$1.24B
(+22%)
Cap. Flow
+$454M
Cap. Flow
% of AUM
6.54%
Top 10 Holdings %
Top 10 Hldgs %
16.4%
Holding
1,110
New
146
Increased
497
Reduced
266
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVR
NVR
|
+$34.9M |
| 2 |
SBA Communications
SBAC
|
+$31.5M |
| 3 |
Lennox International
LII
|
+$29.1M |
| 4 |
McKesson
MCK
|
+$24.8M |
| 5 |
Cable One
CABO
|
+$23.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$55.8M |
| 2 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.7M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$42.5M |
| 4 |
Intuitive Surgical
ISRG
|
+$35.5M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$33.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.87% |
| 2 | Financials | 16.58% |
| 3 | Consumer Discretionary | 13.8% |
| 4 | Industrials | 12.36% |
| 5 | Healthcare | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
Universal Technical Institute
UTI
$2.08B
| $119K | ﹤0.01% |
34,925
| – | – |
|
|
PCTI
927
DELISTED
PCTEL, Inc. Common Stock
PCTI
| $117K | ﹤0.01% |
+23,392
| New | +$119K |
|
928
SandRidge Energy
SD
$510M
| $114K | ﹤0.01% |
14,200
| – | – |
|
929
KALA BIO
KALA
$11.8M
| $103K | ﹤0.01% |
5
-15
| -75% | -$266K |
|
930
IDT Corp
IDT
$1.6B
| $98K | ﹤0.01% |
14,800
+1,600
| +12% | +$10.7K |
|
|
JNCE
931
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $96K | ﹤0.01% |
+15,500
| New | +$74.9K |
|
932
SIGA Technologies
SIGA
$223M
| $95K | ﹤0.01% |
+15,846
| New | +$106K |
|
|
GLDD
933
DELISTED
Great Lakes Dredge & Dock
GLDD
| $93K | ﹤0.01% |
+10,400
| New | +$80.9K |
|
|
GCAP
934
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $93K | ﹤0.01% |
+14,800
| New | +$98.4K |
|
|
CTG
935
DELISTED
Computer Task Group, Inc.
CTG
| $91K | ﹤0.01% |
21,053
+9,486
| +82% | +$40.3K |
|
936
Aspen Aerogels
ASPN
$387M
| $90K | ﹤0.01% |
35,137
+24,184
| +221% | +$71.9K |
|
937
Syndax Pharmaceuticals
SNDX
$1.84B
| $85K | ﹤0.01% |
16,200
-26,739
| -62% | -$153K |
|
938
Riverview Bancorp
RVSB
$107M
| $80K | ﹤0.01% |
10,900
| – | – |
|
939
Arbutus Biopharma
ABUS
$865M
| $78K | ﹤0.01% |
+21,796
| New | +$83.7K |
|
940
IRIDEX
IRIX
$15.5M
| $74K | ﹤0.01% |
16,295
-2,768
| -15% | -$12.8K |
|
|
SCPH
941
DELISTED
scPharmaceuticals
SCPH
| $71K | ﹤0.01% |
+23,696
| New | +$81.4K |
|
942
LSI Industries
LYTS
$853M
| $65K | ﹤0.01% |
+24,585
| New | +$79K |
|
|
APEN
943
DELISTED
Apollo Endosurgery, Inc.
APEN
| $64K | ﹤0.01% |
+17,004
| New | +$59.5K |
|
944
Dawson Geophysical
DWSN
$155M
| $63K | ﹤0.01% |
21,602
-41,206
| -66% | -$148K |
|
|
LITS
945
Lite Strategy Inc
LITS
$33.6M
| $53K | ﹤0.01% |
857
-1,347
| -61% | -$77.2K |
|
946
INNOVATE Corp
VATE
$114M
| $50K | ﹤0.01% |
2,044
-13,826
| -87% | -$431K |
|
|
PES
947
DELISTED
Pioneer Energy Services Corp.
PES
| $47K | ﹤0.01% |
+26,635
| New | +$45.9K |
|
|
ASNA
948
DELISTED
Ascena Retail Group, Inc.
ASNA
| $17K | ﹤0.01% |
+805
| New | +$36.1K |
|
|
VIVS
949
VivoSim Labs
VIVS
$1.46M
| $11K | ﹤0.01% |
46
-101
| -69% | -$25.4K |
|
950
Adeia
ADEA
$2.86B
| – | – |
-62,344
| Closed | -$303K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2019 Portfolio in Review
As of Q1 2019, Jacobs Levy Equity Management held 1,110 positions worth $6.93B, up 22% from $5.69B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Jacobs Levy Equity Management deployed $454M of net new capital in Q1 2019, opening 146 new positions and adding to 497 existing holdings. Its largest new stake was AbbVie: 282,010 shares worth $22.7M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Wellcare Health Plans, Inc., an estimated $52.7M trimmed.
- Jacobs Levy Equity Management's largest Q1 2019 buy was AbbVie: 282,010 shares worth $22.7M.
- Jacobs Levy Equity Management added most to NVR in Q1 2019, an estimated $34.9M increase.
- Jacobs Levy Equity Management's biggest Q1 2019 reduction was Wellcare Health Plans, Inc., cutting an estimated $52.7M.
- Jacobs Levy Equity Management fully exited Celgene Corp in Q1 2019, selling an estimated $55.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 16% of its $6.93B portfolio in Q1 2019.
- Jacobs Levy Equity Management opened 146 new positions and closed 160 in Q1 2019.
- Jacobs Levy Equity Management's portfolio value rose 22% quarter-over-quarter to $6.93B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2019, filed 14 May 2019.